$S&P 500(.SPX)$ in a wider range from 6600-6700 for now. If SPX can get through 6680 we can see 6700 test this week. Calls can work above 6680 this week. $Robinhood(HOOD)$ up 12% today. If HOOD can hold above 134 as a higher low tomorrow we can see 140 quickly.HOOD Oct 3 140C is best above 136 $Strategy(MSTR)$ breakout today with $BTC. BTC above 115 can run to 121K. IF this occurs, MSTR can run to 342-350MSTR Oct 3 335C is best above 325 Let's see if the gov't shutdown happens tomorrow and how the market reacts to $TSLA delivery numbers + NFP data on Friday, Good luck tmrw everyone!! 🫡For whom haven't open CBA can know more from below:🏦 Open a CBA today and e
1. $Vail(MTN)$ releases earnings after the closing bell(Monday). Expected move is 8% and IV is low. The daily chart definitely looks like a "mountain". 😂Current price is trading at the edge of the last solid volume support level. Not sure how we want to #Optionselling trade this. Looking at a put-write trade, Oct 17 expiry, strike somewhere in the 100-130 range (either lots of contracts around 100 or 1 contract at 130).Image2. $Paychex(PAYX)$ releases earnings before market open on Tuesday. Expected move is 6.5% and IV is low, so the expectation is that the stock price won't move much. We shall see.Strong volume support around the 120 level, which also happens to be the lower bound of the expected move.Mig
A Sleeping Giant is AWAKENING: (1) For over a year, $Sunrise New Energy(EPOW)$ traded along $1 price line like a sleeping giant. (2) a few days ago, this small manufacturer of graphite anode material for lithium-ion batteries SUDDENLY awakened, with huge volume. (3) Watching it NOW, make me proud!A line chart displaying stock price movements for EPOW over time, with a horizontal axis showing dates and a vertical axis showing price levels. A blue trendline slopes downward across the chart. Text overlays include "NPAW" with "PRICE CHART" and "SUNRISE" next to an image of rocky terrain and water.For whom haven't open CBA can know more from below:🏦 Open a CBA today and enjoy privileges of up to SGD 20,000 in trading limit with 0 commission. Trade SG,
LYFT, COIN, AMD, NKE& WYNN Welcome Great Upward Momentum Now!
Hello everyone! Today i want to share some technical analysis with you!1. $Wynn(WYNN)$ Insiders know how to WYNN.Image2. $Nike(NKE)$ EARNINGS DAY TODAY. ✔️Options flow is leaning bearish.But they’ve beaten 8 straight quarters, and Polymarket odds give them an ~82% chance to beat again.Image3. $Advanced Micro Devices(AMD)$ Volume Point of Control = $160Love it above, sketchy below it. 🍿Image4.Watch ATH ⚓️ VWAP tomorrow.If $Coinbase Global, Inc.(COIN)$ claims it, the gap doesn’t stay unfilled for long.Image5. $Lyft, Inc.(LYFT)$ Not sure how this one wasn't on the watchlist, but you
Options puppy : Market Master 101: My Take on Howard Marks’ Defensive Memo 📜
Market Master 101: My Take on Howard Marks’ Defensive Memo 📜 Howard Marks has always been a voice of reason during both euphoric rallies and painful downturns. His latest memo emphasizes caution, noting that while markets are elevated, we are not yet in the kind of irrational exuberance seen in past bubbles. What resonates with me is his call for “Level 5 defense,” which doesn’t mean hiding in cash, but rather trimming excessive risk and positioning portfolios in a way that cushions against volatility. As an investor, I find his words timely. With the Magnificent 7 and the S&P 500 priced at elevated multiples, it makes sense to focus not just on returns, but also on risk management. ⸻ The Magnificent 7 and Lofty Valuations 💻📱 The Magnificent 7—Nvidia, Apple, Microsoft, Alphabet, Amazon
AI Agent Revolution: Anthropic's 30-Hour Marathon vs. OpenAI's Lifestyle Takeover!
On September 30, the $Invesco QQQ(QQQ)$ index closed slightly higher at 0.46%, yet the underlying driving forces were exceptionally robust: Anthropic unveiled its Claude Sonnet 4.5 model, while OpenAI pursued a two-pronged strategy: partnering with Stripe to integrate shopping features into ChatGPT and preparing to launch Sora 2, a video-generating social app.Anthropic's Claude Sonnet 4.5: From "7 Hours of Autonomy" to "30-Hour Marathon," the Era of AI Agents Officially BeginsFirst, let's discuss Anthropic's groundbreaking update. The Claude Sonnet 4.5 model officially launched today, with its core selling point being a leap in autonomous operation capability—jumping directly from the 7-hour limit of the previous Opus 4 model to 30 hours of continu
From Mag 7 to 'Mag 10': The New AI Playbook Wall Street's most influential stock portfolio, the "Magnificent 7," is facing a redefinition as investors search for a new cohort that more fully reflects the beneficiaries of the AI revolution. Several new concepts are emerging to capture the true winners of AI. Signaling a shift beyond the original seven, Cboe Global Markets announced earlier this month the launch of futures and options based on its new Cboe Magnificent 10 Index. This "Magnificent 10" index includes the original seven—Nvidia, Microsoft, Apple, Alphabet, Amazon, and Meta Platforms —plus Broadcom , Palantir , and Advanced Micro Devices. The exchange cited criteria such as "liquidity, market cap, trading volume, and leadership in areas like artificial intelligence and digital tra
EURCAD Bounces Back: Reaction Higher from Blue Box Area
In this technical blog, we will look at the past performance of the 1-hour Elliott Wave Charts of EURCAD. In which, the rally from 02 September 2025 low unfolded as impulse sequence & showed a higher high sequence therefore, called for an extension higher to take place. We knew that the structure in EURCAD should remain supported & extend higher. So, we advised members not to sell the pair & buy the dips in 3, 7, or 11 swings at the blue box areas. We will explain the structure & forecast below: EURCAD 1-Hour Elliott Wave Chart From 9.19.2025 Here’s the 1-hour Elliott wave Chart from the 9.19.2025 Asia update. In which, the rally to 1.6359 high completed small wave (i) & made a pullback in wave (ii). The internals of that pullback unfolded as Elliott wave zigzag&nb
The Hidden Costs of Fiat Currency: Navigating Devaluation and Protecting Your Portfolio
In an era where central banks wield unprecedented control over money supply, fiat currency—the government-issued legal tender not backed by a physical commodity like gold—dominates global economies. From the U.S. dollar to the euro, these currencies derive their value from trust in issuing authorities rather than intrinsic worth. While fiat systems enable flexible monetary policies to stimulate growth, they also sow seeds of instability through inflation and devaluation, eroding savers' purchasing power over time. As of September 2025, with U.S. inflation ticking up to 2.9% annually in August, investors are increasingly questioning how to safeguard their wealth against these forces. This article explores the ripple effects of fiat currency on economies and investments, then outlines practi
As I look at the recent buzz around Intel's $Intel(INTC)$ potential comeback, I'm intrigued by the news that they've approached Apple $Apple(AAPL)$ for a possible investment and closer collaboration. The idea of the struggling chipmaker teaming up with the iPhone giant is certainly exciting, even if the talks are still in early stages and might not lead to an immediate deal. I can see why this lifted investor sentiment—Intel's shares closing 6% higher on Wednesday is a strong signal of optimism. When it comes to whether Intel is still a buy at $30, I'd say it's a tough call without diving deeper into the financials. The potent
I don’t think the gold-silver ratio will fall back to even 50. Although silver is the poor man’s gold, gold has a different status. Gold is the basis for currencies and the go to for investors during uncertainties. Comparatively, silver seems second tier that investors buy when gold seems out of reach or gold has rallied too much that investors do not want to risk getting their fingers burnt with it. I don’t think silver will hit $100. I do expect a pullback soon unless there are many piling into it because gold has gotten out of reach and they want commodities as part of their portfolio to ride the uncertain times ahead. Also, these uncertainties may not last and that will send both gold and silver dropping. I do not buy comodities as they are speculative to me. There is no basis for
Identify Stocks with Growth Potential from Three Perspectives
The growth potential of a company can be an important consideration when making investment decisions, as it might help investors determine whether a company is likely to offer potentially higher returns in the long run. But how can we assess a company's growth potential? We can focus on the following three key indicators. 1. Revenue Growth Revenue growth can be an important indicator of a company's performance. When assessing a company's revenue growth, here are three key considerations to keep in mind. First, the absolute value of the growth rate. A company might look more attractive if its revenue grows more than 20% on a year-on-year basis with steady and consistent quarterly growth. Second, the growth rate change: an increase in the growth rate over time is more ideal. Third, industry
I agree fully with his views. There is no way around except to agree that valuations of the magnificent 7 and s&p500 are high yet not in irrational exuberance. With expected rate cuts for the rest of the year, that should continue to drive stock prices up. So, I agree with his strategy to reduce aggressive positions and to increase defensive positions. However, I would do this closer to the year end santa rally to try to gain more returns. My portfolio is still heavily on the s&p500. Across the board, it is currently hard to find defensive assets at attractive prices. For now, I would try to take profit at a later time to yield cash so that I can buy during dips. I think from next year onwards, cash might be king when the market corrects or potentially a recession. I would prefer
🇸🇬 The Price of Austerity—How One Retiree Missed $440k in Yield by Playing It Too Safe) | 🦖 #TheInvestingIguana EP1107
🟩 💸 Are you saving too much at the cost of truly living? In this video, join Iggy the Investing Iguana as we dive into the $440K regret—a lesson in balancing financial discipline with purposeful living. Inspired by Suzuki’s story of extreme frugality and heartbreaking realization, we’re shedding light on how over-optimization can rob us of life’s most meaningful moments. 📊 Packed with insights, we explore the hidden costs of extreme saving, Singapore-specific strategies like CPF and SRS, and Iggy’s step-by-step balance framework. Learn how to automate your savings, protect a "memory budget," and avoid the pitfalls of lifestyle inflation—all while keeping your financial goals intact. ✨ Whether you’re building your REIT portfolio or just looking to make smarter investment decisions, this vid
Trump’s Tariff Bombshell Rocks Markets—100% on Movies and Furniture!
$S&P 500(.SPX)$$NASDAQ(.IXIC)$ Donald Trump just unleashed a trade shock, announcing a 100% tariff on foreign-made movies and hinting at substantial tariffs on countries failing to produce furniture in the U.S., with details pending. The S&P 500 slid to 6,600 after three days of losses, while the U.S. dollar weakened to 99.5 on the DXY, down 0.8%. Nasdaq holds at 22,200, and Bitcoin edges up to $128,500. Will these tariffs ignite inflation or boost domestic industries? How will Hollywood and furniture makers fare? Dive into the market reactions, assess the economic fallout, and strategize your next move in this trade policy upheaval. Tariff Shockwave: What’s Driving the Market Jolt? The announce
$Coinbase Global, Inc.(COIN)$$CME Bitcoin - main 2510(BTCmain)$$Strategy(MSTR)$ 🔥📈🚀 $COIN Back-Tests Gann Arc Jail and Survives. Is $444 Next? 🚀📈🔥 📌 Coinbase defends critical structure, BTC surges, and volatility reloads. The crypto equity king is back in play. 🎯 Gann Square Back-Test Avoids Arc Jail Weekly structure just held the line. $COIN defended the ascending Gann arc from the 2023–2024 confluence and rejected a full breakdown into the lower arc zone near 🔵 $285. This wasn’t just a bounce, it was a macro validation. Now coiling above the diagonal Gann support, price is stabilising at $318.70 with bullish momentum building. ROE sits at 27.96%, P/S at
The market feels tricky right now. The S&P 500 seems range-bound after a few days of decline, but high valuations and gold hitting new highs suggest underlying risk. As a beginner in options, I’m cautious about jumping into an Iron Condor on SPY and prefer to watch the index’s behavior over the next few sessions. Intel’s recent surge is tempting, especially with news of potential investment from Apple. If I hold shares, selling covered calls could lock in some premium while allowing upside. For new positions, a Bull Call Spread limits cost and risk while still providing exposure to potential gains. For now, my focus is on learning and gradually applying options strategies rather than taking aggressive trades. I want to understand strike selection, implied volatility, and risk-reward d
$S&P 500(.SPX)$$Cboe Volatility Index(VIX)$$SPDR S&P 500 ETF Trust(SPY)$$SPDR S&P 500 ETF Trust(SPY)$ 🔥📈⚠️ $SPY Cup & Handle Breakout Completes but $VIX Says Not So Fast 🧠💣📊 🟠 $SPY just executed a clean cup and handle breakout, with the move triggering Sunday and running the full blue band range from $657.00 to $665.80. This isn’t just a technical textbook example; it’s a volatility-fueled expansion into overextended territory. 🔵 That breakout pushed price straight through the upper Keltner and Bollinger bands, and we’ve now tagged the top of the structure. The key level to watch here is $664.31. This is
KALA BIO’s Collapse: A Biotech Dream Turned Nightmare
On September 28, 2025, KALA BIO, Inc. (NASDAQ: KALA) sent shockwaves through the biotech investment community with a devastating announcement: its lead candidate, KPI-012, failed to meet the primary endpoint in the Phase IIb CHASE clinical trial for persistent corneal epithelial defect (PCED). The fallout was swift and brutal—KALA’s stock plummeted 92% in a single trading session, erasing millions in market value and leaving investors scrambling to reassess the company’s future. This article dives into what happened, why it matters, and what’s next for this embattled biotech. The Rise and Fall of KALA BIO KALA BIO, formerly Kala Pharmaceuticals, is a Massachusetts-based biotech focused on therapies for rare and severe eye diseases. Founded in 2009, the company went public in 2017, riding h
$Coinbase Global, Inc.(COIN)$$Strategy(MSTR)$$BitMine Immersion Technologies Inc.(BMNR)$ 🔥🚀📊 Crypto-Equity Synergy Ignites 🔥🚀📊 🚀 $MSTR surged $15+ (+4.9%) intraday, tracking Bitcoin’s rally. Options flow shows a sharp divergence: calls surged +$6.63M while puts collapsed -$5.77M, pushing underlying to $324.79. This is pure leveraged beta at work; watch if it sustains above $325 for continuation. 📈 $COIN broke higher to $330, and the weekly chart shows a textbook cup-and-handle reversal structure. With $290.75 acting as a key floor, the impulsive “Wow Move” is getting close; upside Fibonacci targets stretch toward $358.54 and $444.90. 💡 $BMNR added momentum, cli